Tokyo Tape
Sign in
← Takeda Pharmaceutical

Quarterly report · Q2

4502.TEDINET S100S2Q9
Period2023-04-01 → 2023-09-30
Filed2023-10-30
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 61
MetricValuePeriodScopeSource row
Revenue¥2.10T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Revenue¥1.04T2023-07-01 → 2023-09-30dCons.Revenue IFRS
Revenue¥4.03T2022-04-01 → 2023-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥1.97T2022-04-01 → 2022-09-30Cons.Revenue IFRS
Revenue¥1.00T2022-07-01 → 2022-09-30dCons.Revenue IFRS
Operating income¥119.2bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Operating income−¥49.3bn2023-07-01 → 2023-09-30dCons.Operating profit loss IFRS
Operating income¥255.0bn2022-04-01 → 2022-09-30Cons.Operating profit loss IFRS
Operating income¥104.4bn2022-07-01 → 2022-09-30dCons.Operating profit loss IFRS
Profit before tax¥39.1bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Profit before tax−¥96.0bn2023-07-01 → 2023-09-30dCons.Profit loss before tax IFRS
Profit before tax¥375.1bn2022-04-01 → 2023-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥220.0bn2022-04-01 → 2022-09-30Cons.Profit loss before tax IFRS
Profit before tax¥64.5bn2022-07-01 → 2022-09-30dCons.Profit loss before tax IFRS
Net income (owners)¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)−¥48.0bn2023-07-01 → 2023-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss attributable to owners of parent IFRS
Net income¥41.4bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Net income−¥48.0bn2023-07-01 → 2023-09-30dCons.Profit loss IFRS
Net income¥317.0bn2022-04-01 → 2023-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥166.8bn2022-04-01 → 2022-09-30Cons.Profit loss IFRS
Net income¥61.7bn2022-07-01 → 2022-09-30dCons.Profit loss IFRS
Total assets¥14.87Tat 2023-09-30Cons.Assets IFRS
Total assets¥13.96Tat 2023-03-31Cons.Assets IFRS
Total assets¥14.59Tat 2022-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥7.80Tat 2023-09-30Cons.Liabilities IFRS
Total liabilities¥7.60Tat 2023-03-31Cons.Liabilities IFRS
Net assets / equity¥7.07Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥6.35Tat 2023-03-31Cons.Equity IFRS
Net assets / equity¥6.71Tat 2022-09-30Cons.Equity IFRS
Net assets / equity¥5.68Tat 2022-03-31dCons.Equity IFRS
Equity (owners)¥7.07Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥6.35Tat 2023-03-31Cons.Equity attributable to owners of parent IFRS
Cash & equivalents¥318.1bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥533.5bnat 2023-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥798.1bnat 2022-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥849.7bnat 2022-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥291.3bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥977.2bn2022-04-01 → 2023-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥305.2bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥327.1bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥607.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥121.9bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥198.4bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥709.1bn2022-04-01 → 2023-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow−¥267.6bn2022-04-01 → 2022-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥26.512023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥-30.682023-07-01 → 2023-09-30dCons.Basic earnings loss per share IFRS
EPS (basic)¥204.292022-04-01 → 2023-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥107.622022-04-01 → 2022-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥39.772022-07-01 → 2022-09-30dCons.Basic earnings loss per share IFRS
EPS (diluted)¥26.292023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥-30.682023-07-01 → 2023-09-30dCons.Diluted earnings loss per share IFRS
EPS (diluted)¥201.942022-04-01 → 2023-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥106.882022-04-01 → 2022-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥39.482022-07-01 → 2022-09-30dCons.Diluted earnings loss per share IFRS
Equity ratio47.5%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio45.5%at 2023-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio46.0%at 2022-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 751
ItemContextValueUnit
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row3Member－
Total number of shares held treasury shares etcCurrentQuarterInstant_Row3Member12000
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant7798300
Number of shares held in others names treasury shares etcCurrentQuarterInstant－
Total number of shares held treasury shares etcCurrentQuarterInstant7798300
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0049
Revenue IFRSPrior1YTDDuration1974771000000JPY
Revenue IFRSCurrentYTDDuration2101707000000JPY
Cost of sales IFRSPrior1YTDDuration598327000000JPY
Cost of sales IFRSCurrentYTDDuration664696000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration480214000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration501065000000JPY
Research and development expenditure recognized as expense during period IFRSPrior1YTDDuration297752000000JPY
Research and development expenditure recognized as expense during period IFRSCurrentYTDDuration346687000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSPrior1YTDDuration273643000000JPY
Amortization and impairment losses on intangible assets associated with products IFRSCurrentYTDDuration369665000000JPY
Other operating income IFRSPrior1YTDDuration13476000000JPY
Other operating income IFRSCurrentYTDDuration9874000000JPY
Other operating expenses IFRSPrior1YTDDuration83359000000JPY
Other operating expenses IFRSCurrentYTDDuration110240000000JPY
Operating profit loss IFRSPrior1YTDDuration254953000000JPY
Operating profit loss IFRSCurrentYTDDuration119230000000JPY
Finance income IFRSPrior1YTDDuration75707000000JPY
Finance income IFRSCurrentYTDDuration24312000000JPY
Finance costs IFRSPrior1YTDDuration109272000000JPY
Finance costs IFRSCurrentYTDDuration106095000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration-1366000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration1607000000JPY
Profit loss before tax IFRSPrior1YTDDuration220022000000JPY
Profit loss before tax IFRSCurrentYTDDuration39053000000JPY
Income tax expense IFRSPrior1YTDDuration53269000000JPY
Income tax expense IFRSCurrentYTDDuration-2382000000JPY
Profit loss IFRSPrior1YTDDuration166753000000JPY
Profit loss IFRSCurrentYTDDuration41436000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration166756000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration41365000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration-3000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration71000000JPY
Profit loss IFRSPrior1YTDDuration166753000000JPY
Profit loss IFRSCurrentYTDDuration41436000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration107.62
Basic earnings loss per share IFRSCurrentYTDDuration26.51
Diluted earnings loss per share IFRSPrior1YTDDuration106.88
Diluted earnings loss per share IFRSCurrentYTDDuration26.29
Revenue IFRSPrior1QuarterDuration1002307000000JPY
Revenue IFRSCurrentQuarterDuration1043089000000JPY
Cost of sales IFRSPrior1QuarterDuration305445000000JPY
Cost of sales IFRSCurrentQuarterDuration343582000000JPY
Selling general and administrative expenses IFRSPrior1QuarterDuration248734000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 16 of 16 passed
balance sheet identityconsolidated 2023-03-31pass
balance sheet identityconsolidated 2023-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2022-07-01/2022-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2023-07-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2022-04-01/2022-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2022-04-01/2022-09-30pass
statement vs summary · revenueconsolidated 2022-07-01/2022-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2023-07-01/2023-09-30pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-09-30pass